Alchemist share price
BSE: 526707Pharmaceuticals & Biotechnology
Trading suspended since 14 Dec 2021
Last traded ₹3.01 on 13 Dec 2021
Latest announcements
Routine notices left out.Share news and announcements
May 2022
2 May · CIRP - others
Apr 2022
Feb 2021
Jan 2021
6 Jan · Statement Of Investor Complaints For The Quarter Ended December 2020
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0 1 0 1
Results
Standalone, as consolidated accounts are on record for only 5 of the last ten years; ₹ crore, the charts by years to March, the table by quarter. No standalone results on record for the year to Mar 2013.Quarterly results
Quarter to Sep 2020, against the quarter beforeFiled 19 Nov
- RevenueRevenue. The pill is the change in revenue against the quarter before: this period's figure divided by that one's, less one, in per cent.
- ₹1.17 Crup 38.66%
- Net profitNet profit. Under it, net profit in the quarter before. A change in per cent is not worked out where either period is a loss or nothing.
- −₹186 CrQuarter to Jun 2020: −₹1.56 Cr
- Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax.
- −15,851.4%
Revenue by year
Net profit by year, a loss in red
- Net profit
- Loss
| ₹ crore | Dec 2018Filed 14 Feb | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020Filed 4 Aug | Jun 2020Filed 15 Sep | Sep 2020Filed 19 Nov |
|---|---|---|---|---|---|---|---|---|
| Revenue | 6 | 6 | 6 | 5 | 3 | 1 | 1 | 1 |
| Net profit | −3 | 7 | −3 | −3 | −1 | −40 | −2 | −186 |
| Net marginNet margin. Net profit as a percentage of revenue: how much of each rupee of sales is left after every cost, interest and tax. | −47.2% | 129.9% | −50.0% | −55.4% | −55.7% | −3,094.2% | −184.7% | −15,851.4% |
Business segments
Share of revenue, year to Mar 2020, consolidated.Segment revenue and profit
- pharma, Chemicals, & mineralspharma, Chemicals, & minerals, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹7.42 Crdown 52.17%51.5%
- agri businessagri business, share of revenue. The segment's revenue as a percentage of the revenue of all the company's reported business segments together, leaving out eliminations between them and unallocated items.₹6.99 Crdown 37.70%48.5%
Where the return came from
Yearly rates to Mar 2020, per-share figures restated for splits and bonuses.
| Over | Return a year | Earnings growth | Change in P/E | Dividend yield |
|---|---|---|---|---|
| 1 year | −38.5% | – | – | 0.0% |
| 3 years | −62.7% | – | – | 0.0% |
| 5 years | −46.4% | – | – | 0.0% |
Dividends
Per share, by the year it was paid for, and the latest payments.Dividend history and dates
| Ex-date | Type | Per share |
|---|---|---|
| 23 Sep 2014 | Final | ₹1.00 |
| 24 Sep 2013 | Final | ₹1.50 |
| 25 Sep 2012 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. | ₹2.00 |
| 22 Sep 2011 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. | ₹2.00 |
| 20 Sep 2010 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. | ₹2.00 |
| 23 Sep 2009 | FinalFinal dividend. Called final by its date: the company did not say which kind it was, and it went ex within six months after the company's year end, the time in which the annual general meeting that declares the final dividend must be held. | ₹2.00 |
Alchemist share price by year
Each calendar year to 2021.
| Year | Close at year end | Change | Highest close | Lowest close |
|---|---|---|---|---|
| 2021BSE close | 3.01 | −55.1% | 6.55 | 2.87 |
| 2020 | 6.70 | +688.2% | 10.95 | 0.75 |
| 2019BSE close | 0.85 | −67.3% | 3.00 | 0.65 |
| 2018 | 2.60 | −82.2% | 14.90 | 1.70 |
| 2017 | 14.60 | −34.7% | 30.15 | 10.70 |
| 2016 | 22.35 | −25.6% | 33.05 | 19.55 |
| 2015 | 30.05 | −9.6% | 41.05 | 20.20 |
Recent sessions
The last 10 trading days to 13 Dec 2021, as traded on BSE.
| Date | Open | High | Low | Close | Average price | Volume |
|---|---|---|---|---|---|---|
| 13 Dec 2021 | 3.00 | 3.01 | 3.00 | 3.01 | 3.01 | 19,973 |
| 6 Dec 2021 | 2.87 | 3.00 | 2.73 | 2.87 | 2.78 | 27,835 |
| 29 Nov 2021 | 3.02 | 3.02 | 2.87 | 2.87 | 2.98 | 14,452 |
| 30 Aug 2021 | 3.15 | 3.15 | 3.15 | 3.15 | 3.15 | 15,338 |
| 23 Aug 2021 | 3.30 | 3.30 | 3.30 | 3.30 | 3.30 | 585 |
| 16 Aug 2021 | 3.45 | 3.45 | 3.45 | 3.45 | 3.45 | 6,495 |
| 9 Aug 2021 | 3.80 | 3.80 | 3.60 | 3.60 | 3.61 | 5,916 |
| 2 Aug 2021 | 3.75 | 3.75 | 3.50 | 3.75 | 3.60 | 37,161 |
| 26 Jul 2021 | 3.80 | 3.95 | 3.65 | 3.65 | 3.73 | 6,084 |
| 19 Jul 2021 | 3.90 | 3.90 | 3.60 | 3.80 | 3.80 | 43,063 |
Price adjustments
What the price chart is corrected for, so it reads as one share held throughout.Share consolidation history
| Ex-date | Event | Price factor | What happened |
|---|---|---|---|
| 5 Jul 2007 | Share count change | – | The company changed its share count by an amount the filing does not state, so earlier prices are not shown. |
| 8 Mar 2007 | Price move | – | Between two trading sessions the price fell 47% or more, or rose 90% or more. No corporate action is on record. Earlier prices are not shown. |
Company details
- Legal name
- Alchemist Limited
- BSE code
- 526707
- ISIN
- INE964B01033
- Industry
- Pharmaceuticals & Biotechnology
- Listed
- Feb 1995
- Face value
- ₹10
- Former symbols
- ALCHEM
- CIN
- L72200DL1988PLC192643
- Corporate identity number, the registrar of companies' code for it